세계의 전자 임상결과평가(eCOA) 솔루션 시장 : 유형별, 도입 모델별, 서비스 유형별, 최종 용도별 - 예측(2024-2032년)

Global Electronic Clinical Outcome Assessment (eCOA) solutions market will grow at 14.3% CAGR during 2024-2032 due to well-established healthcare infrastructure and favorable government initiatives to promote digital healthcare technology. The increasing prevalence of chronic diseases is acting as a major driver for market growth. According to the WHO, non-communicable diseases (NCDs) claim 41 million lives each year, accounting for 74 percent of global deaths. As the population ages and lifestyles change, chronic diseases such as diabetes, cardiovascular diseases, and respiratory diseases are on the rise.

As the burden of these diseases continues to increase, more effective methods are needed to monitor patient outcomes and treatment efficacy. eCOA solutions provide a proactive approach to chronic disease management by enabling remote data collection, real-time monitoring, and personalized interventions. By facilitating timely intervention and improving patient management, eCOA solutions play a crucial role in addressing the challenges of the increasing prevalence of chronic diseases, thereby inducing market growth.

Electronic Clinical Outcome Assessment (eCOA) Solutions industry is classified based on type, deployment model, service type, end use, and region.

The Clinical-Reported Outcomes (ClinRO) segment will grow steadily through 2032, as ClinRO assessments provide valuable information about the impact of interventions on clinical status and the general well-being of patients. In addition, they are more in demand because they can collect clinically relevant data directly from patients. In this way, health professionals can accurately assess the severity of the disease, the effectiveness of the treatment, and the symptoms described by the patient. In addition, the flexibility offered by ClinRO assessments, allowing questionnaires adapted to specific treatment areas, promotes their adoption in various clinical trials.

The electronic clinical outcome assessment market from the healthcare provider segment will grow strongly through 2032 as healthcare providers use eCOA solutions to track patient outcomes, track disease progression, and optimize treatment strategies. As we move towards value-based care and patient-centered healthcare delivery models, healthcare providers are increasingly using eCOA solutions to improve patient care and clinical outcomes. In addition, the integration of eCOA data with electronic health records (EHR) enables seamless data exchange and interoperability, which promotes the adoption of eCOA solutions among healthcare providers.

Europe Electronic Clinical Outcome Assessment industry will grow rapidly through 2032 due to well-established healthcare infrastructure and favorable government initiatives to promote digital healthcare technology. Countries such as the UK, Germany, and France are at the forefront of eCOA adoption and are increasingly investing in clinical trials and research. Europe's strict regulatory environment ensures high standards of data protection and data security, increases stakeholder confidence, and promotes the widespread adoption of eCOA solutions. In addition, collaboration between academia, industry, and regulatory agencies will drive innovation and accelerate the development and adoption of advanced eCOA technologies that will drive market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Gradual shift towards electronic data capturing from paper-based procedures
    • 3.2.1.2 Growing advancements in eCOA modalities
    • 3.2.1.3 Growing adoption of cloud-based services
    • 3.2.1.4 Favorable government support and funding for clinical trials
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High dearth of skilled professionals to operate eCOA
    • 3.2.2.2 Concern about data security and privacy
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Clinician-reported outcome (ClinRO)
• 5.3 Patient-reported outcome (PRO)
• 5.4 Observer-reported outcome (ObsRO)
• 5.5 Performance outcome (PerfO)

Chapter 6 Market Estimates and Forecast, By Deployment Model, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Licensed enterprise (on-premises) solutions
• 6.3 Cloud-based solutions
• 6.4 Web-hosted (on-demand) solutions

Chapter 7 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Bring-your own device model (BYOD)
• 7.3 Provisioned device model

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Pharmaceutical and biopharmaceutical companies
• 8.3 Healthcare providers
  • 8.3.1 Hospitals
  • 8.3.2 Clinics
• 8.4 Contract research organizations (CROs)
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 AssisTek
• 10.2 Climedo Health GmbH
• 10.3 Clinical ink
• 10.4 CRF Health
• 10.5 EvidentIQ
• 10.6 ICON plc
• 10.7 IQVIA
• 10.8 Integra IT S.A.S
• 10.9 Kayentis
• 10.10 Medidata
• 10.11 Oracle Corporation
• 10.12 Raylytic GmbH
• 10.13 Signant Health
• 10.14 Veeva Systems